Targeting deregulated epigenetic control in cancer

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Cancer is characterized by genetic mutations and epigenetic deregulation.
• Key epigenetic mechanisms like histone modifications, DNA methylation, and non-coding RNA silencing are often altered in cancers.
• Epigenetic control, including subnuclear protein localization and gene bookmarking during mitosis, is also dysregulated in cancer.

Purpose of the Study:

• To review the multifaceted roles of epigenetic control in various cancers.
• To discuss the implications of epigenetic alterations for cancer risk assessment.
• To explore the potential of targeting epigenetic mechanisms for early detection and personalized cancer therapy.

Main Methods:

• Literature review of epigenetic mechanisms in cancer.
• Analysis of deregulated epigenetic processes in different cancer types.
• Discussion of the translational potential of epigenetic findings.

Main Results:

• Epigenetic deregulation is a common hallmark across diverse cancers.
• Altered epigenetic mechanisms contribute to cancer development and progression.
• Epigenetic modifications offer potential biomarkers for cancer risk and detection.

Conclusions:

• Epigenetic mechanisms are critical in cancer pathogenesis.
• Understanding epigenetic alterations is key for developing novel cancer therapies.
• Targeting epigenetic pathways holds promise for personalized cancer medicine.